<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Safety Diagnostics for Dose-Escalation Trial Designs — precautionary-package • precautionary</title>

<!-- favicons -->
<link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png" />
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png" />
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png" />
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png" />

<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->

<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous" />

<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Safety Diagnostics for Dose-Escalation Trial Designs — precautionary-package" />
<meta property="og:description" content="Enhances various R packages that support the design and simulation
of phase 1 dose-escalation trials, adding diagnostics to examine the safety
characteristics of these designs in light of expected inter-individual variation
in pharmacokinetics and pharmacodynamics." />
<meta property="og:image" content="https://github.com/dcnorris/precautionary/raw/main/docs/card.png" />
<meta property="og:image:alt" content="Logo for precautionary package" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:creator" content="@davidcnorrismd" />
<meta name="twitter:site" content="@davidcnorrismd" />






<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  

  

  </head>

  <body data-spy="scroll" data-target="#toc">
    

    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">precautionary</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.2.4</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="../articles/DTP-vs-Korn94.html">DTP-vs-Korn94</a>
    </li>
    <li>
      <a href="../articles/FDA-proactive.html">How FDA can vet dose-escalation trials for safety</a>
    </li>
    <li>
      <a href="../articles/Intro.html">Introduction to package 'precautionary'</a>
    </li>
    <li>
      <a href="../articles/MCSE-Free.html">MCSE-Free CRM Performance and Safety Assessment</a>
    </li>
    <li>
      <a href="../articles/Safety-Schematic-via-CPE.html">Generalized dose-escalation safety schematics via Complete Path Enumeration (CPE)</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/dcnorris/precautionary/">
    <span class="fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Safety Diagnostics for Dose-Escalation Trial Designs</h1>
    <small class="dont-index">Source: <a href='https://github.com/dcnorris/precautionary/blob/master/R/precautionary-package.R'><code>R/precautionary-package.R</code></a></small>
    <div class="hidden name"><code>precautionary-package.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Enhances various R packages that support the design and simulation
of phase 1 dose-escalation trials, adding diagnostics to examine the safety
characteristics of these designs in light of expected inter-individual variation
in pharmacokinetics and pharmacodynamics.</p>
    </div>



    <h2 class="hasAnchor" id="references"><a class="anchor" href="#references"></a>References</h2>

    
<ol>
<li><p>Norris DC. Dose Titration Algorithm Tuning (DTAT) should supersede
&#8216;the&#8217; Maximum Tolerated Dose (MTD) in oncology dose-finding trials.
<em>F1000Research</em>. 2017;6:112. doi: <a href='https://doi.org/10.12688/f1000research.10624.3'>10.12688/f1000research.10624.3</a>
.
<a href='https://f1000research.com/articles/6-112/v3'>https://f1000research.com/articles/6-112/v3</a></p></li>
<li><p>Norris DC. Costing &#8216;the&#8217; MTD. <em>bioRxiv</em>. August 2017:150821.
doi: <a href='https://doi.org/10.1101/150821'>10.1101/150821</a>
.
<a href='https://www.biorxiv.org/content/10.1101/150821v3'>https://www.biorxiv.org/content/10.1101/150821v3</a></p></li>
<li><p>Norris DC. Precautionary Coherence Unravels Dose Escalation Designs.
<em>bioRxiv</em>. December 2017:240846. doi: <a href='https://doi.org/10.1101/240846'>10.1101/240846</a>
.
<a href='https://www.biorxiv.org/content/10.1101/240846v1'>https://www.biorxiv.org/content/10.1101/240846v1</a></p></li>
<li><p>Norris DC. One-size-fits-all dosing in oncology wastes money, innovation
and lives. <em>Drug Discov Today</em>. 2018;23(1):4-6.
doi: <a href='https://doi.org/10.1016/j.drudis.2017.11.008'>10.1016/j.drudis.2017.11.008</a>
.
<a href='https://www.sciencedirect.com/science/article/pii/S1359644617303586'>https://www.sciencedirect.com/science/article/pii/S1359644617303586</a></p></li>
<li><p>Norris DC. Costing &#8216;the&#8217; MTD ... in 2-D. <em>bioRxiv</em>. July 2018:370817.
doi: <a href='https://doi.org/10.1101/370817'>10.1101/370817</a>
.
<a href='https://www.biorxiv.org/content/10.1101/370817v1'>https://www.biorxiv.org/content/10.1101/370817v1</a></p></li>
<li><p>Norris DC. Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials.
<em>JAMA Pediatrics</em>. 2019;173(6):609
doi: <a href='https://doi.org/10.1001/jamapediatrics.2019.0811'>10.1001/jamapediatrics.2019.0811</a>
.</p></li>
<li><p>Norris DC. Comment on Wages et al., Coherence principles in interval-based
dose finding. Pharmaceutical Statistics 2019, DOI: 10.1002/pst.1974.
<em>Pharmaceutical Statistics</em>. March 2020.
doi: <a href='https://doi.org/10.1002/pst.2016'>10.1002/pst.2016</a>
.</p></li>
<li><p>Norris DC. Retrospective analysis of a fatal dose-finding trial.
arXiv:2004.12755 [stat.ME]. April 2020.
<a href='https://arxiv.org/abs/2004.12755'>https://arxiv.org/abs/2004.12755</a></p></li>
<li><p>Norris DC. What Were They Thinking? Pharmacologic priors implicit in a choice
of 3+3 dose-escalation design. arXiv:2012.05301 [stat.ME]. December 2020.
<a href='https://arxiv.org/abs/2012.05301'>https://arxiv.org/abs/2012.05301</a></p></li>
</ol>

    <h2 class="hasAnchor" id="author"><a class="anchor" href="#author"></a>Author</h2>

    <p>David C. Norris (<a href='https://orcid.org/0000-0001-9593-6343'>https://orcid.org/0000-0001-9593-6343</a>)</p>

  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p><p>Developed by David C. Norris.</p></p>
</div>

<div class="pkgdown">
  <p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 1.6.1.9001.</p></p>
</div>

      </footer>
   </div>

  


  

  </body>
</html>


